XML 40 R15.htm IDEA: XBRL DOCUMENT
v3.22.2

Revenue (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Revenue |
Schedule of revenue by type and collaboration partner under agreements | ​
​ | ​ | ​ | ​ | ​
​ |  | 6 Months Ended |  | 6 Months Ended
​ | ​ | June 30, 2022 | ​ | June 30, 2021
(DKK million) | ​ | ​ | ​ | ​
Revenue by type: |  | ​ |  |
Royalties |  | 4,727 |  | 2,595
Reimbursement revenue |  | 287 |  | 227
Milestone revenue |  | 176 |  | 731
Collaboration revenue | ​ | 91 | ​ | —
Total |  | 5,281 |  | 3,553
​ | ​ | ​ | ​ | ​
Revenue by collaboration partner: |  | ​ |  | ​
Janssen |  | 4,206 |  | 2,846
AbbVie |  | — |  | 245
Roche | ​ | 390 | ​ | 162
Novartis | ​ | 305 | ​ | 73
BioNTech | ​ | 231 | ​ | 171
Seagen | ​ | 138 | ​ | 56
Other | ​ | 11 | ​ | —
Total |  | 5,281 |  | 3,553
​ | ​ | ​ | ​ | ​
Royalties by product: | ​ | ​ | ​ | ​
DARZALEX |  | 4,024 |  | 2,360
TEPEZZA |  | 390 |  | 162
Kesimpta | ​ | 296 | ​ | 72
Other | ​ | 17 | ​ | 1
Total |  | 4,727 |  | 2,595
​ | ​ | ​ | ​ | ​

X
- Definition The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2021-01-01 -Paragraph 114 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_RevenueAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration